Skip to main navigation Skip to search Skip to main content

Prospective evaluation of first-line erlotinib in advanced non-small cell lung cancer (NSCLC) carrying an activating EGFR mutation: A multicenter academic phase II study in Caucasian patients (FIELT)

  • Jacques de Grève*
  • , Jan van Meerbeeck
  • , Johan F. Vansteenkiste
  • , Lore Decoster
  • , Anne Pascale Meert
  • , Peter Vuylsteke
  • , Christian Focan
  • , Jean Luc Canon
  • , Yves Humblet
  • , Guy Berchem
  • , Benoit Colinet
  • , Danny Galdermans
  • , Lionel Bosquée
  • , Joanna Vermeij
  • , Alex Dewaele
  • , Caroline Geers
  • , Denis Schallier
  • , Erik Teugels
    • *Corresponding author for this work

Research output: Contribution to journal › Article › Research › peer-review

17 Citations (Scopus)

Fingerprint

Dive into the research topics of 'Prospective evaluation of first-line erlotinib in advanced non-small cell lung cancer (NSCLC) carrying an activating EGFR mutation: A multicenter academic phase II study in Caucasian patients (FIELT)'. Together they form a unique fingerprint.
Sort by

Keyphrases

Medicine and Dentistry

Pharmacology, Toxicology and Pharmaceutical Science

Neuroscience

Biochemistry, Genetics and Molecular Biology